Value-Based Care

A new wave of financial risk models is forcing cardiologists to rethink patient care. A software-first approach may hold the key to survival and success.

With its latest FDA clearance, Distalmotion completes a strategic portfolio targeting 3M+ annual outpatient surgeries. Is its DEXTER robot the key to the ASC kingdom?

A Kansas health plan reports near-perfect member satisfaction. But what do these numbers truly reveal about the future of long-term care and the push for data-driven dignity?

The FDA is betting on AI to manage chronic illness. Cadence's new pilot for its hypertension software could rewrite the rules for digital health regulation.

Lurie Children's new facility is more than a pharmacy; it's a look into a new system where hospitals integrate business and care to survive and thrive.

Lucid Diagnostics reports rising revenue and a key insurance win for its EsoGuard test, but its financial future hangs in the balance of a pivotal Medicare decision.

HMI Medical's major acquisition of Lifescan Imaging isn't just about market share; it's a strategic move to build a blueprint for Singapore's future.

With a second Inc. 5000 nod and XPRIZE validation, AgelessRx is proving that aging well is more than a trend—it's a high-growth industrial sector.

As Singaporeans face a decade of poor health in old age, insurer AIA is leading a charge to redefine aging, moving the focus from treatment to prevention.

Vynca's spot on the Inc. 5000 isn't just a business win; it's a validation of a tech-driven, humane approach to serious illness care at scale.

With 2,000% growth and recent profitability, SafeRide Health isn't just a fast-growing company—it's a blueprint for fixing healthcare access with tech.

A meal delivery company's rapid growth reveals a systemic shift in American healthcare, where the dinner plate is becoming a reimbursable clinical tool.

With a 1,647% revenue surge, Tenovi's simplified tech is not just growing a business; it's rewiring patient care and defining the future of health.

For the 10th time, GLOBO is on the Inc. 5000. But its real story isn't just growth; it's how AI and a focus on health equity are changing lives.

A virtual cardiology practice is one of America's fastest-growing firms. It's not just a business success; it's a structural shift in healthcare.

P3 Health Partners stuns Wall Street with a swing to profitability, but a deeper dive reveals one-time gains and a strategic pivot. Is this the new playbook?

A Fort Collins clinic is launching a program that merges psychiatry, functional medicine, and brain-mapping tech to treat co-occurring disorders. Is this the end of fragmented care?

A landmark deal between Johnson & Johnson and ACCESS GPO is accelerating the migration of complex heart procedures to outpatient centers, a move poised to redefine costs, access, and competition in cardiac care.

Starling Oncology just hit positive Adjusted EBITDA, a milestone for its value-based care model. Is this the inflection point for profitability in oncology?

Outset Medical's Q2 results reveal a pivotal moment: a major HCA deal and stronger margins point to a new phase of sustainable growth in the dialysis market.